NCT04323124View on ClinicalTrials.gov

Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants

PHASE1TerminatedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

October 21, 2021

Study Completion Date

October 21, 2021

Conditions
Healthy
Interventions
DRUG

PF-07059013

Participants will recieve PF-07059013

DRUG

Placebo

Participants will recieve placebo

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY